Orforglipron (GLP-1) — Analytical-Grade Research Compound
Orforglipron is a novel non-peptide GLP-1 receptor agonist under investigation for its role in
glucose regulation and metabolic research. Its small-molecule design offers enhanced stability and oral bioavailability,
making it a valuable tool for advanced studies in energy balance and weight-management mechanisms.
Key Research Focus Areas
- Glucose metabolism and insulin response
- Appetite regulation, satiety signaling, and energy balance
- Comparative stability vs. peptide GLP-1 analogs
- Body-composition and weight-management pathways
Compound Details
- Name: Orforglipron (GLP-1)
- Form: Oral tablets
- Content: 6 mg total compound (edit if needed)
- Purity: ≥ 99% (HPLC verified)
- Appearance: White tablets in labeled research container
- Storage: Store cool, dry, and protected from light
Handling & Notes
- Use appropriate laboratory PPE and aseptic technique.
- Record lot number and retain documentation for method reproducibility.
Research Use Only. Not for human consumption, medical, or diagnostic use. By purchasing, you affirm this compound will be used by qualified individuals in a controlled research setting.
